Form 3 Filing for Anbio Biotechnology: Ownership Change

This filing is a Form 3, which reports initial beneficial ownership of securities. Nancy Hartzler, identified as a director of Anbio Biotechnology, has reported her ownership. The filing indicates that Ms. Hartzler does not own any securities as of the reporting date, March 18, 2026. The signature date is April 8, 2026. Ms. Hartzler is based in Frankfurt, Germany.